| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.03 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.26 | 0.03 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |